Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Co-Diagnostics

10/08/2023 22:02

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 31 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 24 cents per
share.
    * Revenue rose 3,837.8% to $197.81 million from a year ago;
analysts expected $500.00 thousand. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Co-Diagnostics Inc shares had risen by 17.1% this
quarter and
lost 48.4% so far this year.
    * The company reported a quarterly loss of $8.92 million.
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $3.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.24          -0.31          Missed
 Mar. 31 2023      -0.22          -0.20          Beat
 Dec. 31 2022      -0.15          -0.68          Missed
 Sep. 30 2022      -0.04          -0.04          Met